The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Latysheva N.V.

Filatova E.G.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Osipova D.V.

Sechenov First Moscow State Medical University, Moscow, Russia

Memory and attention deficit in migraine: overlooked symptoms

Authors:

Latysheva N.V., Filatova E.G., Osipova D.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2): 39‑43

DOI: 10.17116/jnevro201911902139

Read: 9703 times

Contact the author
Table of contents

MEMORY AND ATTENTION DEFICIT IN MIGRAINE: OVERLOOKED SYMPTOMS
MEMORY AND ATTENTION DEFICIT IN MIGRAINE: OVERLOOKED SYMPTOMS

To cite this article:

Latysheva NV, Filatova EG, Osipova DV. Memory and attention deficit in migraine: overlooked symptoms. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2):39‑43. (In Russ.)
https://doi.org/10.17116/jnevro201911902139

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Cognitive impairment after major surgical operations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):74-80
Analysis of cognitive status in patients with different noso­logies and clinical variants of very late mani­festing schi­zophreniform psychosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):88-93
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124
Features of care of patients with cardiovascular diseases and cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):99-104
Cere­brovascular disease in clinical practice. Reso­lution of the Expert Council of the Russian Scientific Medi­cal Society of Therapists. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):105-111
Recu­rrent pain syndromes in adolescents of different ages. Russian Journal of Pain. 2025;(2):24-31
Prophylactic treatment of migraine in real clinical practice. Russian Journal of Pain. 2025;(2):63-69
Biofeedback in complex therapy of pain syndromes. Russian Journal of Pain. 2025;(2):70-75
Abstract:

Objective. To evaluate the prevalence of objective cognitive impairment (CI) in patients with episodic migraine (EM) during the interictal period and in the chronic migraine (CM) population. Material and methods. Sixty-four patients with CM and 42 patients with low-frequency EM (less than 4 headache days a month), aged 18—59, were enrolled. Depression and anxiety were assessed with the Hospital Anxiety and Depression Scale (HADS). Cognitive functions were evaluated with the Montreal Cognitive Assessment scale (MoCA), Digit Symbol Substitution Test (DSST) and the Rey Auditory Verbal Learning Test (RAVLT). Results. In the CM group DSST and MoCA performance as well as the RAVLT total learning index were significantly decreased compared to EM; 38% of CM patients scored lower than 26 points of the MoCA scale. Negative correlations between headache frequency and DSST and MoCA results were observed. There was no correlation between cognitive test performance and anxiety/depression levels. Conclusion. Patients with EM and CM present with objective CI. The prevalence and severity of cognitive deficits rise with increasing headache frequency.

Keywords:

migraine
chronic migraine
cognitive impairment
triptans

Authors:

Latysheva N.V.

Filatova E.G.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Osipova D.V.

Sechenov First Moscow State Medical University, Moscow, Russia

Close metadata

References:

  1. Buse DC, Manack A, Serrano D, Turkel C, Lipton R. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428-432. https://doi.org/10.1136/jnnp.2009.192492
  2. Lipton RB, Manack Adams A, Buse DC, Fanning KM, Reed ML. A comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: demographics and headache-related disability. Headache. 2016;56(8):1280-1289. https://doi.org/10.1111/head.1287
  3. Gil-Gouveia R, Oliveira AG, Martins IP. A subjective cognitive impairment scale for migraine attacks. The MIG-SCOG: Development and validation. Cephalalgia. 2011;31:984-991. https://doi.org/10.1177/0333102411408359
  4. Meyer JS, Thornby J, Crawford K, Rauch G. Reversible cognitive decline accompanies migraine and cluster headaches. Headache. 2000;40:638-646. https://doi.org/10.1046/j.1526-4610.2000.040008638.x
  5. Quintela E, Castillo J, Munoz P, Pascual J. Premonitory and resolution symptoms in migraine: A prospective study in 100 unselected patients. Cephalalgia. 2006;26:1051-1060. https://doi.org/10.1111/j.1468-2982.2006.01157.x
  6. Gil-Gouveia R, Oliveira AG, Martins IP. Cognitive dysfunction during migraine attacks: a study on migraine without aura. Cephalalgia. 2015;35(8):662-674. https://doi.org/10.1177/0333102414553823
  7. Gil-Gouveia R, Martins I. Clinical description of attack-related cognitive symptoms in migraine: A systematic review. Cephalalgia. 2018;38(7):1335-1350. https://doi.org/10.1177/0333102417728250
  8. Caro G, Caro JJ, O’Brien JA, Anton S, Jackson J. Migraine therapy: Development and testing of a patient preference questionnaire. Headache. 1998;38:602-607. https://doi.org/10.1046/j.1526-4610.1998.3808602.x
  9. Huang L, Juan Dong H, Wang X, Wang Y, Xiao Zh. Duration and frequency of migraines affect cognitive function: evidence from neuropsychological tests and event-related potentials. J Headache Pain. 2017;18(1):54. https://doi.org/10.1186/s10194-017-0758-6
  10. Costa A, Sansalone A, Squillace A, Vescio G, Iannacchero R. Self-referred cognitive impairment in migraine patients. J Headache Pain. 2015;16(suppl 1): 149. https://doi.org/10.1186/1129-2377-16-s1-a149
  11. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629-808. https://doi.org/10.1177/0333102413485658
  12. Geffen G, Moar KJ, O’hanlon AP, Clark CR, Geffen LB. Performance measures of 16— to 86-year-old males and females on the auditory verbal learning test. Clinical Neuropsychologist. 1990;4(1):45-63. https://doi.org/10.1080/13854049008401496
  13. Munir F, Jones D, Leka S, Griffiths A. Work limitations and employer adjustments for employees with chronic illness. Int J Rehabil Res. 2005;28:111-117. https://doi.org/10.1097/00004356-200506000-00003
  14. Latysheva NV, Filatova EG, Osipova DV. Memory and attention deficit in chronic migraine. Nervno-myshechnye Bolezni. 2018;8(2):10-16. (In. Russ.) https://doi.org/10.17650/2222-8721-2018-8-2-10-16
  15. Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 2015;84(7):688-695. https://doi.org/10.1212/WNL.0000000000001256
  16. Edwards KR, Rosenthal BL, Farmer KU, Cady R, Browning R. Evaluation of sumatriptan-naproxen in the treatment of acute migraine: A placebo-controlled, double-blind, cross-over study assessing cognitive function. Headache. 2013;53(4):656-664. https://doi.org/10.1111/head.12052
  17. Farmer K, Cady R, Bleiberg J, Reeves D, Putnam G, O’Quinn S, Batenhorst A. Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study. Headache. 2001;41(4):377-384. https://doi.org/10.1046/j.1526-4610.2001.111006377.x
  18. Osipova VV. Effective relief of migraine attacks: a realistic objective. Medicinskij Sovet. 2017;1:42-46. (In Russ.) https://doi.org/10.21518/2079-701X-2017-0-42-46
  19. Tabeeva GR, Azimova YuE. Efficacy of sumamigren at early and late stages of migraine attack. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2007;107(8):29-34. (In Russ.)
  20. Tabeeva GR, Gromova SA. A comparative analysis on the efficacy of sumamigren in treatment menstrual and non-menstrual migraine attacks. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2011;111(7):44-48. (In Russ.)
  21. Li AV, Parkhomenko EV, Barinov AN. Vestobular migraine: diagnostic difficulties and treatment optimization. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117(8):59-66. (In Russ.) https://doi.org/10.17116/jnevro20171178159-66
  22. Santangelo G, Russo A, Trojano L, Falco F, Marcuccio L, Siciliano M, Conte F, Garramone F, Tessitore A, Tedeschi G. Cognitive dysfunctions and psychological symptoms in migraine without aura: a cross-sectional study. J Headache Pain. 2016;17(1):76. https://doi.org/10.1186/s10194-016-0667-0
  23. Kalaydjian A, Zandi PP, Swartz KL, Eaton WW, Lyketsos C. How migraines impact cognitive function: findings from the Baltimore ECA. Neurology. 2007;68(17):1417-1424. https://doi.org/10.1212/01.wnl.0000268250.10171.b3
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.